- Home
- SIF vs MRNS Comparison
SIF vs MRNS Comparison
Compare SIF & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIF
- MRNS
- Stock Information
- Founded
- SIF 1913
- MRNS 2003
- Country
- SIF United States
- MRNS United States
- Employees
- SIF N/A
- MRNS N/A
- Industry
- SIF Office Equipment/Supplies/Services
- MRNS Biotechnology: Pharmaceutical Preparations
- Sector
- SIF Industrials
- MRNS Health Care
- Exchange
- SIF Nasdaq
- MRNS Nasdaq
- Market Cap
- SIF 21.7M
- MRNS 19.0M
- IPO Year
- SIF N/A
- MRNS 2014
- Fundamental
- Price
- SIF $3.88
- MRNS $0.32
- Analyst Decision
- SIF
- MRNS Buy
- Analyst Count
- SIF 0
- MRNS 12
- Target Price
- SIF N/A
- MRNS $4.28
- AVG Volume (30 Days)
- SIF 18.7K
- MRNS 4.3M
- Earning Date
- SIF 12-27-2024
- MRNS 11-12-2024
- Dividend Yield
- SIF N/A
- MRNS N/A
- EPS Growth
- SIF N/A
- MRNS N/A
- EPS
- SIF N/A
- MRNS N/A
- Revenue
- SIF $101,482,000.00
- MRNS $31,466,000.00
- Revenue This Year
- SIF N/A
- MRNS $20.74
- Revenue Next Year
- SIF N/A
- MRNS $32.38
- P/E Ratio
- SIF N/A
- MRNS N/A
- Revenue Growth
- SIF 25.24
- MRNS 1.63
- 52 Week Low
- SIF $2.87
- MRNS $0.26
- 52 Week High
- SIF $5.96
- MRNS $11.26
- Technical
- Relative Strength Index (RSI)
- SIF 53.59
- MRNS 27.16
- Support Level
- SIF $3.50
- MRNS $0.30
- Resistance Level
- SIF $3.68
- MRNS $0.33
- Average True Range (ATR)
- SIF 0.18
- MRNS 0.03
- MACD
- SIF 0.05
- MRNS 0.04
- Stochastic Oscillator
- SIF 62.16
- MRNS 38.45
About SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.
About MRNS Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.